Latest Lovenox news
Fewer Major Bleeds With Once- Versus Twice-Daily Enoxaparin
posted February 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Once-daily enoxaparin is associated with fewer major bleeds than enoxaparin twice daily in patients with acute venous thromboembolism, according to a study published online Jan. 25 in the Journal of Thrombosis and Haemostasis.
Editor's Recommendations
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
New Guideline Details Diagnosis, Treatment of Acute Pulmonary Embolism .jpg)
Guideline Updated for Early Management of Acute Ischemic Stroke 
Continuing Oral Anticoagulants After ≥90 Days Tied to Lower Risk for Recurrent VTE Related Articles
Elevated INR in Older Adults on Warfarin May Not Be Tied to Risk for Brain Bleeding After Head Trauma 
Bleeding Risks for Oral Anticoagulants and Aspirin Mostly Similar 
Fewer Bleeding Events Seen With Abelacimab Than Rivaroxaban in A-Fib Monthly Specialist Briefings
Stay Connected
